Methods relating to intestinal organ-on-a-chip

Patent metadata

Field	Value
Publication number	US-11976304-B2
Application number	US-202117539452-A
Country	US
Kind code	B2
Filing date	Dec 1, 2021
Priority date	Sep 13, 2016
Publication date	May 7, 2024
Grant date	May 7, 2024

Abstract

Described herein are methods for providing an in vitro intestinal model system, e.g., using primary cells instead of cell lines and/or cancerous cells.

First claim

What is claimed herein is:

1. A method of providing an in vitro intestinal model system, the method comprising:
a) providing i) an intestinal enteroid or colonoid comprising primary intestinal epithelial cells, ii) a microfluidic culture device, the device comprising a porous membrane having first and second surfaces, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid, and iii) intestinal endothelial cells;
b) disrupting said intestinal enteroid or colonoid comprising primary intestinal epithelial cells into enteroid fragments or colonoid fragments, wherein each of said enteroid fragments and said colonoid fragments comprises groups of from 2 to 100 intestinal epithelial cells;
c) seeding said second surface of said porous membrane with said enteroid fragments or colonoid fragments so as to create seeded primary intestinal epithelial cells and establish a culture of said intestinal endothelial cells on said first surface of said porous membrane;
d) expanding said seeded primary intestinal epithelial cells so as to create a monolayer of cells; and
e) differentiating said monolayer of cells so as to create two or more different differentiated intestinal cell types.

2. The method of claim 1 , wherein said epithelial monolayer is exposed to a fluid from said source of fluid at a flow rate whereupon an intact intestinal barrier forms.

3. The method of claim 2 , further comprising measuring the permeability of said intestinal barrier.

4. The method of claim 1 , wherein said different differentiated intestinal cell types comprise absorptive enterocytes, Paneth cells, goblet cells, and enteroendocrine cells.

5. The method of claim 4 , wherein at least one of said differentiated intestinal cell types exhibits mucus secretion.

6. The method of claim 1 , wherein step b) comprises disrupting in the presence of a ROCK inhibitor.

7. The method of claim 6 , wherein the ROCK inhibitor is Y27632.

8. The method of claim 1 , wherein the method further comprises step f) maintaining the culture of the intestinal epithelial cells in the microfluidic culture device.

9. The method of claim 8 , wherein the maintaining step comprises providing the epithelial cells with expansion medium comprising one or more of the following: Win-3A, EGF; Rspo 1; Noggin; gastrin; TGF-β receptor inhibitor; and p38 MAPK inhibitor.

10. The method of claim 8 , wherein the maintaining step comprises providing the epithelial cells with expansion medium comprising Wnt-3A; EGF; Rspo 1; Noggin; gastrin; TGF-13 receptor inhibitor; and p38 MAPK inhibitor.

11. The method of claim 1 , the method further comprising: providing fibroblasts; and establishing a culture of said fibroblasts on said first surface of said porous membrane with said endothelial cells.

12. The method of claim 11 , wherein said fibroblasts are cultured on a hydrogel on said membrane.

13. The method of claim 1 , wherein said epithelial monolayer is exposed to a fluid from said source of fluid at a flow rate whereupon intestinal villi form.

14. The method of claim 13 , further comprising step (f) forming said intestinal villi at a reproducibility that is at least twice the reproducibility as when seeding said second surface of said porous membrane with single cells that had been dissociated from said enteroids.

15. The method of claim 1 , wherein said epithelial monolayer is exposed to a fluid from said source of fluid at a flow rate whereupon intestinal folds form.

16. The method of claim 1 , further comprising step (f) forming said two or more different differentiated intestinal cell types at a reproducibility that is at least twice the reproducibility as when seeding said second surface of said porous membrane with single cells that had been dissociated from said enteroids.

17. A method of providing an in vitro intestinal model system, the method comprising:
a) providing i) an intestinal enteroid or colonoid comprising primary intestinal epithelial cells,
ii) a microfluidic culture device, the device comprising a porous membrane having first and second surfaces, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid, and iii) intestinal endothelial cells;
b) disrupting said intestinal enteroid or colonoid comprising primary intestinal epithelial cells into enteroid fragments or colonoid fragments, wherein each of said enteroid fragments and said colonoid fragments comprises groups of from 2 to 100 intestinal epithelial cells and of from 10 μm to 500 μm in diameter;
c) seeding said second surface of said porous membrane with said enteroid fragments or colonoid fragments so as to create seeded primary intestinal epithelial cells and establish a culture of said intestinal endothelial cells on said first surface of said porous membrane;
d) expanding said seeded primary intestinal epithelial cells so as to create a monolayer of cells; and
e) differentiating said monolayer of cells so as to create two or more different differentiated intestinal cell types.

18. The method of claim 17 , wherein each of said enteroid fragments and said colonoid fragments comprise groups of from 40 μm to 100 μm in diameter.

19. The method of claim 17 , wherein said epithelial monolayer is exposed to a fluid from said source of fluid at a flow rate whereupon an intact intestinal barrier forms.

20. The method of claim 19 , further comprising measuring a permeability of said intestinal barrier.

21. The method of claim 17 , wherein said different differentiated intestinal cell types comprise absorptive enterocytes, Paneth cells, goblet cells, and enteroendocrine cells.

22. The method of claim 21 , wherein at least one of said differentiated intestinal cell types exhibits mucus secretion.

23. The method of claim 17 , wherein step b) comprises disrupting in the presence of a ROCK inhibitor.

24. The method of claim 23 , wherein the ROCK inhibitor is Y27632.

25. The method of claim 17 , wherein the method further comprises step f) maintaining the culture of the intestinal epithelial cells in the microfluidic culture device.

26. The method of claim 25 , wherein the maintaining step comprises providing the epithelial cells with expansion medium comprising one or more of the following: Win-3A, EGF; Rspo 1; Noggin; gastrin; TGF-β receptor inhibitor; and p38 MAPK inhibitor.

27. The method of claim 25 , wherein the maintaining step comprises providing the epithelial cells with expansion medium comprising Wnt-3A; EGF; Rspo 1; Noggin; gastrin; TGF-β receptor inhibitor; and p38 MAPK inhibitor.

28. The method of claim 17 , the method further comprising: providing fibroblasts; and establishing a culture of said fibroblasts on said first surface of said porous membrane with said endothelial cells.

29. The method of claim 28 , wherein said fibroblasts are cultured on a hydrogel on said membrane.

30. The method of claim 17 , wherein said epithelial monolayer is exposed to a fluid from said source of fluid at a flow rate whereupon intestinal villi form.

31. The method of claim 30 , further comprising step (f) forming said intestinal villi at a reproducibility that is at least twice the reproducibility as when seeding said second surface of said porous membrane with single cells that

Assignees

• Harvard College

Inventors

• Ingber Donald E
• Kasendra Magdalena
• Sontheimer-Phelps Alexandra
• Tovaglieri Alessio

Classifications

• C12N5/0697 Primary

  Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691) · CPC title

• C12N5/0062

  General methods for three-dimensional culture · CPC title

• C12N5/0068

  General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

• C12N5/0679

  Cells of the gastro-intestinal tract · CPC title

• G01N33/5088

  of vertebrates · CPC title